Alex Goldberg

NASDAQ Active Stock Watch List: Gilead Sciences Inc. (NASDAQ:GILD) and Broadcom Corp. (NASDAQ:BRCM) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/21/2014 -- -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Gilead Sciences Inc. (NASDAQ:GILD) and Broadcom Corp. (NASDAQ:BRCM).

Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia is currently up (+0.77%) on 5,035,956 shares traded. Gilead Sciences Inc. (NASDAQ:GILD) is currently up (+101.01%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Gilead Sciences Inc. (NASDAQ:GILD)

Broadcom Corp. (NASDAQ:BRCM) a company that provides semiconductor solutions for wired and wireless communications is currently down (-0.13%) on 1,280,952 shares traded after Broadcom Corporation Introduced New Global Navigation Satellite System for Wearable Fitness Technology. Broadcom Corp. (NASDAQ:BRCM) is currently down (-18.68%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Broadcom Corp. (NASDAQ:BRCM)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com